Skip to content

dr. Piette Yves

Reumatologie
contactgegevens
07/01/2022
Reumatologie

Poussée sévère d’une dermatomyosite pré-existante chez une patiente avec un adénocarcinome pulmonaire traité par pembrolizumab, un anti-PD-1 [Life-threatening flare of an underlying «paraneoplastic» dermatomyositis in a patient with lung adenocarcinoma treated with anti-PD-1 pembrolizuma].

Rev Med Liege. 2022 Jul;77(7-8):462-467. French. PMID: 35924504.dr. Piette Yves
07/01/2022
Reumatologie

Myositis specific and associated autoantibodies (MSA-ab).

Neuromuscul Disord. 2022 Jul;32(7):594-608. doi: 10.1016/j.nmd.2022.05.011. Epub 2022 May 20. PMID: 35644723.dr. Piette Yves
04/11/2022
Reumatologie

Standardised interpretation of capillaroscopy in autoimmune idiopathic inflammatory myopathies: A structured review on behalf of the EULAR study group on microcirculation in Rheumatic Diseases.

Autoimmun Rev. 2022 Apr 11:103087. doi: 10.1016/j.autrev.2022.103087. PMID: 35421608 Review.dr. Piette Yves
03/11/2022
Reumatologie

Off-label use of mycophenolate mofetil in the treatment of rare and complex rheumatic connective tissue diseases.

Clin Exp Rheumatol. 2022 Mar 11. doi: 10.55563/clinexprheumatol/v1e7s2. Online ahead of print. PMID: 35349418dr. Piette Yves
02/11/2022
Reumatologie

Positioning of myositis-specific and associated autoantibody (MSA/MAA) testing in disease criteria and routine diagnostic work-up.

J Transl Autoimmun. 2022 Feb 11;5:100148. doi: 10.1016/j.jtauto.2022.100148. eCollection 2022.PMID: 35243286dr. Piette Yves
06/12/2023
Reumatologie

Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies.

Clin Exp Rheumatol. 2022 Feb;40(2):274-283. Epub 2022 Feb 16.PMID: 35200123dr. Piette Yves
06/12/2023
Reumatologie

Anti-RuvBL1/2 autoantibodies in patients with systemic sclerosis or idiopathic inflammatory myopathy and a nuclear speckled pattern.

Ann Rheum Dis. 2022 Jan 13:annrheumdis-2021-220004. doi: 10.1136/annrheumdis-2021-220004.dr. Piette Yves
08/01/2021
Reumatologie

Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders: A retrospective cohort study.

Semin Arthritis Rheum. 2021 Aug 1;51(5):969-976. doi: 10.1016/j.semarthrit.2021.07.018.dr. Piette Yves
01/01/2021
Reumatologie

Idiopathische inflammatoire myopathieën (deel 1, 2 en 3).

Tijdschrift voor geneeskunde. REUMATOLOGIE 2021, Volume 1, DOI: 10.47671/TVG.77.20.168dr. Piette Yves
07/01/2020
Reumatologie

Development of eosinophilic fasciitis during treatment with certolizumab pegol for ankylosing spondylitis.

Clin Exp Rheumatol. 2020 Jul-Aug;38(4):799.dr. Piette Yves
07/04/2019
Reumatologie

Pitfalls in the detection of myositis specific antibodies by lineblot in clinically suspected idiopathic inflammatory myopathy.

Clin Exp Rheumatol. 2019 Jul 4.dr. Piette Yves
06/12/2023
Reumatologie

Idiopathic inflammatory myopathies: narrative review of unmet needs in clinical practice guidelines.

RMD Open. 2019 Feb 26;4(Suppl 1):e000784. doi: 10.1136/rmdopen-2018-000784. eCollection 2018. Review.dr. Piette Yves
01/11/2019
Reumatologie

Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays.

Autoimmun Rev. 2019 Mar;18(3):293-305. doi: 10.1016/j.autrev.2018.10.004. Epub 2019 Jan 11. Review.dr. Piette Yves
01/02/2019
Reumatologie

RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients.

Nat Commun. 2019 Jan 2;10(1):9. doi: 10.1038/s41467-018-07911-6.dr. Piette Yves
11/01/2007
Reumatologie

Correlative imaging in crowned dens syndrome.

Clin Nucl Med. 2007 Nov;32(11):854-7. PubMed PMID: 18075419.dr. Piette Yves
10/01/2016
Reumatologie

Anakinra in resistant gout: a case report.

Acta Clin Belg. 2016 Oct 7:1-3. [Epub ahead of print] PubMed PMID: 27712511.dr. Piette Yves
01/01/1970
Reumatologie

Assessment of sensitivity to change of the European Scleroderma Study Group activity index.

Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):148-151. PubMed PMID: 27463733.dr. Piette Yves
01/01/1970
Reumatologie

Disease activity indices in systemic sclerosis: a systematic literature review.

Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):186-192. Review. PubMed PMID: 27385265.dr. Piette Yves
07/01/2016
Reumatologie

EULAR Study Group on Microcirculation in Rheumatic Diseases. Nailfold Capillaroscopy and Clinical Applications in Systemic Sclerosis.

Microcirculation. 2016 Jul;23(5):364-72. doi: 10.1111/micc.12281. Review. PubMed PMID: 27086648.dr. Piette Yves
06/01/2016
Reumatologie

Six-minute walk test in systemic sclerosis: A systematic review and meta-analysis.

Int J Cardiol. 2016 Jun 1;212:265-73. doi: 10.1016/j.ijcard.2016.03.084. PubMed PMID: 27057932.dr. Piette Yves
05/01/2016
Reumatologie

Stabilization of Microcirculation in Patients with Early Systemic Sclerosis with Diffuse Skin Involvement following Rituximab Treatment: An Open-label Study.

J Rheumatol. 2016 May;43(5):995-6. doi: 10.3899/jrheum.151018. PubMed PMID:27134280.dr. Piette Yves
02/01/2016
Reumatologie

The heart and pulmonary arterial hypertension in systemic sclerosis.

Acta Clin Belg. 2016 Feb;71(1):1-18. doi: 10.1080/17843286.2015.1108538. PubMed PMID: 27075793.dr. Piette Yves
01/01/1970
Reumatologie

IgG4-related disease: The utility of (18)F-FDG PET/CT in diagnosis and treatment.

Hell J Nucl Med. 2015 Sep-Dec;18 Suppl 1:155-9. PubMed PMID: 26672716.dr. Piette Yves
12/01/2013
Reumatologie

Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis.

J Rheumatol. 2013 Dec;40(12):2023-8. doi: 10.3899/jrheum.130528. PubMed PMID: 24128778.dr. Piette Yves
01/01/2013
Reumatologie

Two-year results of an open pilot study of a 2-treatment course with rituximab in patients with early systemic sclerosis with diffuse skin involvement.

J Rheumatol. 2013 Jan;40(1):52-7. doi: 10.3899/jrheum.120778. PubMed PMID: 23118116.dr. Piette Yves
03/08/2012
Reumatologie

Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement?

Ann Rheum Dis. 2012 Oct;71(10):1636-9. doi: 10.1136/annrheumdis-2011-200780. Epubdr. Piette Yves
Reumatologie

Allogeneic stem cell transplantation in refractory rheuma toid arthritis: A case report.

Mons2022-09-23dr. Piette Yves
Reumatologie

KBVR Working group on rare connective tissue diseases: Where are we and where do we want to go?

Mons2022-09-23dr. Piette Yves
Reumatologie

Myositis specific and associated autoantibodies (MSA-ab).

Hoofddorp, The Netherlands2021-11-08dr. Piette Yves
Reumatologie

Workshop on electromyography.

Brussel2021-01-01dr. Piette Yves
Reumatologie

Systemic diseases.

Brussel2021-01-01dr. Piette Yves
Reumatologie

Physicians’ reasons for prescribing Janus kinase inhibitors (JAKi) in patients with rheumatoidarthritis, and associated alignment between physicians and patients in a real-world clinical setting.

2021-01-01dr. Piette Yves
Reumatologie

A rare case of adult-onset phalangeal microgeodic syndrome.

Brussel2021-01-01dr. Piette Yves
Reumatologie

hysician and patient attitudes towards treat-to-target, its implementation and stated treatment goals in patients with rheumatoid arthritis in a real-world setting across Europe.

Brussel2021-01-01dr. Piette Yves
Reumatologie

Prevalence of clinical symptoms and laboratory markers in idiopathic inflammatory myopathies.

virtual edition, 20212021-01-01dr. Piette Yves
Reumatologie

The impact of temperature on the evaluation of myositis specific antibodies by lineblot.

Leuvendr. Piette Yves
Reumatologie

Fast track algorithm: how to differentiate a scleroderma pattern from a non-scleroderma pattern.

Madriddr. Piette Yves
Reumatologie

Case report.

Gentdr. Piette Yves
Reumatologie

20th Belgian Congres on Rheumatology. Quiz.

Charleroidr. Piette Yves
Reumatologie

Rare cases of bone fragility or disorders (case reports).

La Hulpedr. Piette Yves
Reumatologie

Assessment of Sensitivity to Change of the Disease Activity Score (DAS) in Systemic Sclerosis (SSc).

Romedr. Piette Yves
Reumatologie

Four years follow-up of an open-label pilot study of treatment with rituximab in patients with early, diffuse cutaneous systemic sclerosis.

Brusseldr. Piette Yves
Reumatologie

Two years follow-up results of a multicenter, open-label pilot study with rituximab in patients with early, diffuse cutaneous systemic sclerosis.

Brusseldr. Piette Yves
Reumatologie

Stabilisation of microcirculation in patients with early systemic sclerosis with diffuse skin involvement treated with rituximab.

Oostende + San Diegodr. Piette Yves
Reumatologie

Synovial fluid derived invariant Natural Killer T cells in chronic arthritides show an increased Programmed Death-1 expression and anerghic phenotype.

La Hulpedr. Piette Yves
Reumatologie

Two years follow-up results of an open pilot study of fixed repeated treatment with rituximab in patients with “early” systemic sclerosis with diffuse skin involvement.

Antwerpen + Chicagodr. Piette Yves